Efficacy and Safety of Bromfenac 0.09% and Sodium Hyaluronate 0.4% Combination Therapy, Versus Placebo in Patients With Pterygium I–III for Clinical Signs on Ocular Inflammation

Clinical Ophthalmology - New Zealand
doi 10.2147/opth.s203648

Related search